This inventor holds 12 USPTO granted patents and 2 published patent applications and 1 EPO patent. Top assignee: Eli Lilly and Company. Active years: 2006-2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2006-2017
Title: The Innovative Contributions of Rohn Lee Millican, Jr.
Introduction
Rohn Lee Millican, Jr., based in Indianapolis, IN, is a prominent inventor known for his significant contributions to the field of biopharmaceuticals. With an impressive portfolio that includes 12 patents, his innovations are primarily focused on addressing various autoimmune diseases and metabolic conditions.
Latest Patents
Among Millican's latest patents are groundbreaking developments in bispecific antibodies and GLP-1 analog fusion proteins. His patent on Anti-TNF-/anti-IL-23 bispecific antibodies revolves around antibodies that effectively bind to Tumor Necrosis Factor alpha (TNFα) and the p19 subunit of Interleukin-23 (IL-23p19). These antibodies demonstrate high affinity and strong simultaneous neutralizing properties, presenting promising treatment options for autoimmune conditions such as Inflammatory Bowel Disease, including Crohn's Disease and Ulcerative Colitis, as well as Rheumatoid Arthritis and Psoriatic Arthritis.
Additionally, his innovation regarding GLP-1 analog fusion proteins presents specific GLP-1 analogs fused to IgG4-Fc derivatives. These proteins offer increased half-life and decreased immunogenicity, making them invaluable in the treatment of diabetes, obesity, and other gastrointestinal conditions by effectively managing plasma glucose levels and inhibiting food intake.
Career Highlights
Rohn Lee Millican, Jr. is currently affiliated with Eli Lilly and Company, a leading firm in the pharmaceutical industry. His work within Eli Lilly has positioned him as a key figure in biopharmaceutical research and development.
Collaborations
Throughout his career, Millican has collaborated with notable scientists such as Wolfgang Glaesner and Lianshan Zhang. These collaborations have resulted in advancements that contribute significantly to the field, highlighting the importance of teamwork in achieving innovation in therapeutic solutions.
Conclusion
In summary, Rohn Lee Millican, Jr. exemplifies the spirit of innovation through his contributions to modern medicine. His patents not only reflect his expertise and creativity as an inventor but also his commitment to improving the lives of individuals affected by autoimmune diseases and metabolic disorders.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile